Free Account Opening + AMC Free Demat
Loading...

AGS Transact IPO vs Medplus Health IPO

Comparision between AGS Transact IPO and Medplus Health IPO.

IPO Details

AGS Transact IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Medplus Health IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of AGS Transact IPO is up to ₹680.00 Cr whereas the issue size of the Medplus Health IPO is up to ₹1,398.30 Cr. The final issue price of AGS Transact IPO is ₹175.00 per share and of Medplus Health IPO is ₹796.00 per share.

  AGS Transact IPO Medplus Health IPO
Face Value ₹10 per share ₹2 per share
Issue Price (Lower) ₹166.00 per share ₹780.00 per share
Issue Price (Upper) ₹175.00 per share ₹796.00 per share
Issue Price (Final) ₹175.00 per share ₹796.00 per share
Discount (Retail)
Discount (Employee) ₹78.00 per share
Market Lot Size 85 shares 18 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹600.00 Cr
OFS Issue Size
OFS Issue Size (Amount) up to ₹680.00 Cr up to ₹798.30 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹680.00 Cr up to ₹1,398.30 Cr

IPO Timetable

AGS Transact IPO opens on Jan 19, 2022, while Medplus Health IPO opens on Dec 13, 2021. The closing date of AGS Transact IPO and Medplus Health IPO is Jan 21, 2022, and Dec 15, 2021, respectively.

  AGS Transact IPO Medplus Health IPO
Anchor Bid Date
Issue Open Jan 19, 2022 Dec 13, 2021
Issue Close Jan 21, 2022 Dec 15, 2021
Basis Of Allotment (Tentative) Jan 27, 2022 Dec 20, 2021
Initiation of Refunds (Tentative) Jan 28, 2022 Dec 21, 2021
Credit of Share (Tentative) Jan 31, 2022 Dec 22, 2021
Listing date (Tentative) Jan 31, 2022 Dec 23, 2021
Anchor Lockin End date 1 Feb 26, 2022 Jan 19, 2022
Anchor Lockin End date 2 Apr 27, 2022 Mar 20, 2022

Financials

AGS Transact IPO P/E ratio is , as compared to Medplus Health IPO P/E ratio of .

  AGS Transact IPO Medplus Health IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in Millions)
  31-Aug-21 31-Mar-21 31-Mar-20
Total Assets 29,170.33 29,138.32 22,413.95
Total Revenue 7,623.04 17,971.52 18,335.26
Profit After Tax - 181.05 547.92 830.14
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in Millions)
30-Sep-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 17,464.94 15,656.58 13,486.96 9,587.11
Total Revenue 18,908.99 30,908.14 28,878.87 22,849.40
Profit After Tax 663.67 631.11 17.94 119.22
Promoter Shareholding (Pre-Issue) 98.23% 43.16%
Promoter Shareholding (Post-Issue) 66.07% 40.43%
P/E Ratio
Market Cap ₹2106.87 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the AGS Transact IPO retail investors (RII) are offered 1,43,37,348 shares while in Medplus Health IPO retail investors are offered 1,43,37,348 shares. Qualified institutional buyers (QIB) are offered 81,92,770 shares in AGS Transact IPO and 35,72,550 shares in Medplus Health IPO.

  AGS Transact IPO Medplus Health IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 81,92,770 shares 35,72,550 shares
NII 61,44,578 shares 26,79,414 shares
RII 1,43,37,348 shares 62,51,965 shares
Employee 0 shares 71,225 shares
Others
Total 2,86,74,696 shares 1,25,75,154 shares

Bids Received (Subscription)

AGS Transact IPO subscribed 7.79x in total, whereas Medplus Health IPO subscribed 52.59x.

  AGS Transact IPO Medplus Health IPO
QIB (times) 2.68x 111.90x
NII (times) 25.61x 85.33x
Big NII (times)
Small NII (times)
RII (times) 3.08x 5.24x
Employee (times) 3.05x
Other (times)
Total (times) 7.79x 52.59x

Comments

Add a public comment...